tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
Holding BLTE?
Track your performance easily

Belite Bio, Inc. ADR (BLTE) Financial Statements

26 Followers

Belite Bio, Inc. ADR Financial Overview

Belite Bio, Inc. ADR's market cap is currently ―. The company's EPS TTM is $-1.108; its P/E ratio is -57.87; Belite Bio, Inc. ADR is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Dec 21
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.16M$ 42.09M$ 0.00$ 17.34M
Total Assets$ 94.64M$ 44.27M$ 51.06M$ 18.35M
Total Debt$ 886.00K$ 866.00K$ 0.00$ 0.00
Net Debt$ -87.27M$ -41.22M$ 0.00$ -17.34M
Total Liabilities$ 4.21M$ 2.77M$ 1.43M$ 33.44M
Stockholders Equity$ 90.43M$ 41.50M$ 49.63M$ -15.09M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

Belite Bio, Inc. ADR Debt to Assets

Belite Bio, Inc. ADR Cash Flow

Belite Bio, Inc. ADR Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis